Market Cap 162.41M
Revenue (ttm) 19.09M
Net Income (ttm) -82.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -430.23%
Debt to Equity Ratio 0.00
Volume 300,264
Avg Vol 917,300
Day's Range N/A - N/A
Shares Out 31.35M
Stochastic %K 18%
Beta 0.62
Analysts Strong Sell
Price Target $30.17

Company Profile

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 7000
Address:
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States
StockScanners
StockScanners Jul. 18 at 8:34 AM
$LENZ keep watch if this holds above 4.95
0 · Reply
SoSickofWinning
SoSickofWinning Jul. 18 at 1:43 AM
$LENZ This will take time and I can see why it has value. I also know someone bought 1000 shares at one point for 50k and I bought mine for 5k. So I like my position. Holding long and we will see.
0 · Reply
extrodyne
extrodyne Jul. 15 at 3:55 PM
$LENZ YIKES. Imagine if you worked there. OOF. Bye-bye.
1 · Reply
extrodyne
extrodyne Jul. 15 at 3:51 PM
$LENZ One of the legendary tankings. 50ish to 4ish in a year. Writing's on the wall. Donezo.
0 · Reply
Max_Regards
Max_Regards Jul. 15 at 2:51 PM
$LENZ man this thing has zero floor. Like $0 might be the actual floor. Nico you tried to warn me and I did not listen. Looking for a buyout or solid bounce on some type of positive catalyst to leverage out. Best of luck to us that are in deep.
2 · Reply
CEMBP_Trader
CEMBP_Trader Jul. 15 at 3:45 AM
$LENZ 👀 Sideline waiting. Cheap based on cash per share, but also burning massive cash. Can’t find a solid reason to get in now.
4 · Reply
bowchaser
bowchaser Jul. 14 at 7:56 PM
$LENZ Volume keeps climbing, pps keeps falling to nearly half the cash value. Something weird is definitely going on. The balance sheet must have been thrown out the window.
4 · Reply
Abundance11
Abundance11 Jul. 14 at 6:51 PM
$LENZ No Immediate Structure Below: Because the stock has never traded this low, there are no historical horizontal support lines to rely on. Psychologically, $4.50 and $4.00 are the next natural magnets if sellers remain in control. ​Prior Support is Now Resistance: The previous floor of $5.20 has now flipped into immediate overhead resistance. For any bounce to be considered a true reversal rather than a dead-cat bounce, the stock needs to reclaim and close above $5.20 on strong volume. ​Oversold Territory: The intraday drop has pushed the daily RSI down into the high 30s. While it is heavily oversold, "cheap can get cheaper" when a stock enters price discovery to the downside.
1 · Reply
bedazzled
bedazzled Jul. 13 at 7:14 PM
$LENZ Anyone notice this has a 106% institutional ownership and 30+% short position. No insiders selling and a few have bought at a much higher than this price. I need to do a little research, but I think I like it.
1 · Reply
TickrTalk0007
TickrTalk0007 Jul. 12 at 1:52 AM
$LENZ this is going to be under $2 when sales data comes out
0 · Reply
Latest News on LENZ
Lenz Therapeutics price target lowered to $20 from $26 at Citi

2026-05-13T10:43:53.000Z - 2 months ago

Lenz Therapeutics price target lowered to $20 from $26 at Citi


LENZ Therapeutics trading halted, volatility trading pause

2026-05-12T19:26:31.000Z - 2 months ago

LENZ Therapeutics trading halted, volatility trading pause


LENZ Therapeutics trading resumes

2026-05-12T19:21:07.000Z - 2 months ago

LENZ Therapeutics trading resumes


Lenz Therapeutics price target raised to $31 from $29 at BofA

2026-05-12T14:13:30.000Z - 2 months ago

Lenz Therapeutics price target raised to $31 from $29 at BofA


Lenz Therapeutics reports Q1 EPS ($1.32), consensus ($1.07)

2026-05-11T23:50:20.000Z - 2 months ago

Lenz Therapeutics reports Q1 EPS ($1.32), consensus ($1.07)


LENZ Therapeutics Earnings Call Transcript: Q1 2026

May 11, 2026, 4:30 PM EDT - 2 months ago

LENZ Therapeutics Earnings Call Transcript: Q1 2026


LENZ Therapeutics Earnings release: Q1 2026

May 11, 2026, 4:30 PM EDT - 2 months ago

LENZ Therapeutics Earnings release: Q1 2026


LENZ Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:30 PM EDT - 2 months ago

LENZ Therapeutics Quarterly report: Q1 2026


LENZ Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

LENZ Therapeutics Proxy statement: Proxy filing


LENZ Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

LENZ Therapeutics Proxy statement: Proxy filing


Lenz Therapeutics price target lowered to $26 from $52 at Citi

2026-03-26T10:31:04.000Z - 4 months ago

Lenz Therapeutics price target lowered to $26 from $52 at Citi


Lenz Therapeutics price target lowered to $29 from $35 at BofA

2026-03-25T11:22:03.000Z - 4 months ago

Lenz Therapeutics price target lowered to $29 from $35 at BofA


LENZ Therapeutics Earnings Call Transcript: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 4 months ago

LENZ Therapeutics Earnings Call Transcript: Q4 2025


LENZ Therapeutics Annual report: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 4 months ago

LENZ Therapeutics Annual report: Q4 2025


LENZ Therapeutics Earnings release: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 4 months ago

LENZ Therapeutics Earnings release: Q4 2025


Lenz Therapeutics reports Q4 EPS ($1.16), consensus (90c)

2026-03-24T12:16:56.000Z - 4 months ago

Lenz Therapeutics reports Q4 EPS ($1.16), consensus (90c)


Lenz Therapeutics announces submission of MAA to EMA for VIZ

2026-03-10T12:38:41.000Z - 4 months ago

Lenz Therapeutics announces submission of MAA to EMA for VIZ


LENZ Therapeutics Slides: Corporate presentation

Feb 24, 2026, 7:00 AM EST - 5 months ago

LENZ Therapeutics Slides: Corporate presentation


LENZ Therapeutics to Present at Upcoming Investor Conferences

Feb 23, 2026, 8:00 AM EST - 5 months ago

LENZ Therapeutics to Present at Upcoming Investor Conferences


Citi says buy Lenz Therapeutics on ‘FAERS induced’ selloff

2026-02-19T20:55:33.000Z - 5 months ago

Citi says buy Lenz Therapeutics on ‘FAERS induced’ selloff


LENZ Therapeutics Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:30 AM EST - 9 months ago

LENZ Therapeutics Earnings Call Transcript: Q3 2025


LENZ Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 8:30 AM EST - 9 months ago

LENZ Therapeutics Earnings release: Q3 2025


LENZ Therapeutics Slides: Corporate Presentation

Nov 4, 2025, 6:00 PM EST - 9 months ago

LENZ Therapeutics Slides: Corporate Presentation


LENZ Therapeutics Transcript: Study Update

Aug 1, 2025, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Transcript: Study Update


LENZ Therapeutics Press release: Study Update

Aug 1, 2025, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Press release: Study Update


LENZ Therapeutics Quarterly report: Q2 2025

Jul 30, 2025, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Quarterly report: Q2 2025


LENZ Therapeutics Earnings release: Q2 2025

Jul 30, 2025, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Earnings release: Q2 2025


LENZ Therapeutics Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Earnings Call Transcript: Q1 2025


LENZ Therapeutics Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Quarterly report: Q1 2025


LENZ Therapeutics Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Earnings release: Q1 2025


LENZ Therapeutics Slides: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Slides: Q1 2025


LENZ Therapeutics Transcript: Status Update

Apr 15, 2025, 2:00 PM EDT - 1 year ago

LENZ Therapeutics Transcript: Status Update


LENZ Therapeutics Earnings Call Transcript: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Earnings Call Transcript: Q4 2024


LENZ Therapeutics Annual report: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Annual report: Q4 2024


LENZ Therapeutics Earnings release: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Earnings release: Q4 2024


LENZ Therapeutics Slides: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Slides: Q4 2024


LENZ Therapeutics to Host Commercial Day on April 15, 2025

Mar 3, 2025, 8:00 AM EST - 1 year ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025


LENZ Therapeutics Earnings Call Transcript: Q3 2024

Nov 6, 2024, 8:00 AM EST - 1 year ago

LENZ Therapeutics Earnings Call Transcript: Q3 2024


LENZ Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 8:00 AM EST - 1 year ago

LENZ Therapeutics Quarterly report: Q3 2024


LENZ Therapeutics Earnings release: Q3 2024

Nov 6, 2024, 8:00 AM EST - 1 year ago

LENZ Therapeutics Earnings release: Q3 2024


LENZ Therapeutics Slides: Q3 2024

Nov 6, 2024, 8:00 AM EST - 1 year ago

LENZ Therapeutics Slides: Q3 2024


Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS


LENZ Therapeutics Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

LENZ Therapeutics Earnings Call Transcript: Q2 2024


LENZ Therapeutics Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

LENZ Therapeutics Quarterly report: Q2 2024


LENZ Therapeutics Earnings release: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

LENZ Therapeutics Earnings release: Q2 2024


LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 14, 2024, 4:05 PM EDT - 2 years ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results


LENZ Therapeutics Slides: KOL Event Presentation

Jun 18, 2024, 7:00 AM EDT - 2 years ago

LENZ Therapeutics Slides: KOL Event Presentation


LENZ Therapeutics Slides: Corporate Presentation

Jun 13, 2024, 7:00 AM EDT - 2 years ago

LENZ Therapeutics Slides: Corporate Presentation


LENZ Therapeutics Earnings Call Transcript: Q1 2024

May 8, 2024, 4:00 PM EDT - 2 years ago

LENZ Therapeutics Earnings Call Transcript: Q1 2024


LENZ Therapeutics Quarterly report: Q1 2024

May 8, 2024, 4:00 PM EDT - 2 years ago

LENZ Therapeutics Quarterly report: Q1 2024


LENZ Therapeutics Earnings release: Q1 2024

May 8, 2024, 4:00 PM EDT - 2 years ago

LENZ Therapeutics Earnings release: Q1 2024


LENZ Therapeutics Transcript: Study Result

Apr 3, 2024, 7:00 AM EDT - 2 years ago

LENZ Therapeutics Transcript: Study Result


LENZ Therapeutics Press release: Study Result

Apr 3, 2024, 7:00 AM EDT - 2 years ago

LENZ Therapeutics Press release: Study Result


LENZ Therapeutics Slides: Study Result

Apr 3, 2024, 7:00 AM EDT - 2 years ago

LENZ Therapeutics Slides: Study Result


StockScanners
StockScanners Jul. 18 at 8:34 AM
$LENZ keep watch if this holds above 4.95
0 · Reply
SoSickofWinning
SoSickofWinning Jul. 18 at 1:43 AM
$LENZ This will take time and I can see why it has value. I also know someone bought 1000 shares at one point for 50k and I bought mine for 5k. So I like my position. Holding long and we will see.
0 · Reply
extrodyne
extrodyne Jul. 15 at 3:55 PM
$LENZ YIKES. Imagine if you worked there. OOF. Bye-bye.
1 · Reply
extrodyne
extrodyne Jul. 15 at 3:51 PM
$LENZ One of the legendary tankings. 50ish to 4ish in a year. Writing's on the wall. Donezo.
0 · Reply
Max_Regards
Max_Regards Jul. 15 at 2:51 PM
$LENZ man this thing has zero floor. Like $0 might be the actual floor. Nico you tried to warn me and I did not listen. Looking for a buyout or solid bounce on some type of positive catalyst to leverage out. Best of luck to us that are in deep.
2 · Reply
CEMBP_Trader
CEMBP_Trader Jul. 15 at 3:45 AM
$LENZ 👀 Sideline waiting. Cheap based on cash per share, but also burning massive cash. Can’t find a solid reason to get in now.
4 · Reply
bowchaser
bowchaser Jul. 14 at 7:56 PM
$LENZ Volume keeps climbing, pps keeps falling to nearly half the cash value. Something weird is definitely going on. The balance sheet must have been thrown out the window.
4 · Reply
Abundance11
Abundance11 Jul. 14 at 6:51 PM
$LENZ No Immediate Structure Below: Because the stock has never traded this low, there are no historical horizontal support lines to rely on. Psychologically, $4.50 and $4.00 are the next natural magnets if sellers remain in control. ​Prior Support is Now Resistance: The previous floor of $5.20 has now flipped into immediate overhead resistance. For any bounce to be considered a true reversal rather than a dead-cat bounce, the stock needs to reclaim and close above $5.20 on strong volume. ​Oversold Territory: The intraday drop has pushed the daily RSI down into the high 30s. While it is heavily oversold, "cheap can get cheaper" when a stock enters price discovery to the downside.
1 · Reply
bedazzled
bedazzled Jul. 13 at 7:14 PM
$LENZ Anyone notice this has a 106% institutional ownership and 30+% short position. No insiders selling and a few have bought at a much higher than this price. I need to do a little research, but I think I like it.
1 · Reply
TickrTalk0007
TickrTalk0007 Jul. 12 at 1:52 AM
$LENZ this is going to be under $2 when sales data comes out
0 · Reply
embrace_ur_elements
embrace_ur_elements Jul. 10 at 3:18 AM
$LENZ do we have script data?
0 · Reply
jGoooo
jGoooo Jul. 9 at 1:32 PM
0 · Reply
jGoooo
jGoooo Jul. 8 at 6:30 PM
1 · Reply
ajmrtxl
ajmrtxl Jul. 8 at 2:43 PM
$LENZ 's latest data on SqueezeFinder
0 · Reply
BillionerOfKing
BillionerOfKing Jul. 7 at 9:51 PM
$LENZ Current Stock Price: $5.89 Contracts to trade: $5.0 LENZ Jul 17 2026 Call Entry: $0.65 Exit: $1.08 ROI: 67% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
jGoooo
jGoooo Jul. 7 at 6:50 PM
0 · Reply
JRobb66
JRobb66 Jul. 7 at 6:45 PM
0 · Reply
Sergey_stockdoc
Sergey_stockdoc Jul. 7 at 4:20 PM
1 · Reply
KingChessStudios
KingChessStudios Jul. 7 at 4:10 PM
$LENZ yes
0 · Reply
Disvan
Disvan Jul. 6 at 6:50 PM
$LENZ was that a 2nd bounce at 5.23?
1 · Reply
philipv777
philipv777 Jul. 6 at 12:39 PM
$LENZ don't particularly like the shortterm implications of this telemed launch ... suggests uptake hasn't particularly improved over the last month
2 · Reply
Rmccall
Rmccall Jul. 5 at 6:13 AM
$LENZ anyone brave enough to tell me why happened to this very promising company? Thanks
2 · Reply